KOLIGO THERAPEUTICS

Koligo Therapeutics’ mission is to develop, manufacture, and commercialize transformative cell therapies for the treatment of pancreatic diseases.Koligo is dedicated to supporting their mission while respecting their values.Their employees agree in writing to certain professional standards to codify our mutual understanding of Koligo’s ethics and conduct .

#SimilarOrganizations #People #Financial #Website #More

KOLIGO THERAPEUTICS

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2016-01-01

Address:

Louisville, Kentucky, United States

Country:

United States

Website Url:

http://www.kyslecel.com

Total Employee:

1+

Status:

Active

Contact:

40202 1-502-242-5890

Email Addresses:

[email protected]

Total Funding:

3.65 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 AWS Global Accelerator WPForms

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

stuart-williams_image

Stuart Williams
Stuart Williams koligo therapeutics @ Koligo therapeutics
koligo therapeutics
2018-01-01

david-blanford_image

David Blanford
David Blanford Chief Financial Officer @ Koligo therapeutics
Chief Financial Officer
2018-06-01

mike-hughes_image

Mike Hughes
Mike Hughes Co-Founder, Chief Executive Officer @ Koligo therapeutics
Co-Founder, Chief Executive Officer
2018-05-01

stuart-k-williams_image

Stuart K. Williams
Stuart K. Williams VP & Chief Technology Officer @ Koligo therapeutics
VP & Chief Technology Officer
2018-03-01

matthew-lehman_image

Matthew Lehman
Matthew Lehman Chief Executive Officer, Co-Founder @ Koligo therapeutics
Chief Executive Officer, Co-Founder
2016-03-01

Founder

matthew-lehman_image

Matthew Lehman

mike-hughes_image

Mike Hughes

Investors List

bergen-asset-management_image

Bergen Asset Management

Bergen Asset Management investment in Post-IPO Debt - Koligo therapeutics

Official Site Inspections

http://www.kyslecel.com Semrush global rank: 6.73 M Semrush visits lastest month: 840

Host Informations
Whois Informations

Loading ...

More informations about "Koligo therapeutics" on Search Engine